CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2018; 37(01): 58-62
DOI: 10.1055/s-0038-1625979
Case Report | Relato de Caso
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Pseudotumor Cerebri Presenting Unilateral Papilledema Associated with Iron-deficiency Anemia

Pseudotumor cerebral apresentando papiledema unilateral associado a anemia ferropriva
Fernando Antônio de Oliveira Costa
1   Escola Paulista de Medicina, Pelotas, Rio Grande do Sul, Brazil
,
Othello Moreira Fabião Neto
1   Escola Paulista de Medicina, Pelotas, Rio Grande do Sul, Brazil
,
Guilherme Gago
2   Universidade Católica de Pelotas, Pelotas, Rio Grande do Sul, Brazil
,
Otávio Garcia Martins
3   Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil
,
Frederico de Lima Gibbon
2   Universidade Católica de Pelotas, Pelotas, Rio Grande do Sul, Brazil
,
Leonardo Mendes Nogueira
2   Universidade Católica de Pelotas, Pelotas, Rio Grande do Sul, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

29. September 2017

18. Dezember 2017

Publikationsdatum:
08. März 2018 (online)

Abstract

Pseudotumor cerebri is a relatively common pathology that is characterized by intracranial hypertension in the absence of mass lesions. It commonly affects young and obese women, and its presentation with visual loss and bilateral papilledema is well-described in the literature. We present a case of a 44-year-old, non-obese, female patient presenting with unilateral papilledema and iron-deficiency anemia. This case emphasizes this unusual presentation and the rare association with iron deficiency.

Resumo

O pseudotumor cerebral é uma patologia relativamente comum, caracterizada pela hipertensão intracraniana na ausência de lesões causando efeito de massa. Frequentemente afeta mulheres jovens e obesas, e sua apresentação, com perda do campo visual e papiledema bilateral, é bem descrita na literatura. Nós apresentamos um caso de uma paciente de 44 anos, não obesa, com papiledema unilateral e anemia ferropriva. Esse caso destaca essa apresentação incomum e a rara associação com a deficiência de ferro.

 
  • References

  • 1 Corbett J. Idiopathic intracranial hypertension. J Neuroophthalmol 2012; 32 (03) e4-e6
  • 2 Corbett JJ. The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983; 10 (04) 221-229
  • 3 Daniels AB, Liu GT, Volpe NJ. , et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007; 143 (04) 635-641
  • 4 Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45 (08) 875-877
  • 5 Friedman DI. Idiopathic intracranial hypertension with Dan and beyond: the 2010 Jacobson Lecture. J Neuroophthalmol 2010; 30 (04) 380-385
  • 6 Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clin Proc 1994; 69 (02) 169-180
  • 7 Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993; 50 (01) 78-80
  • 8 Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114 (Pt 1A): 155-180
  • 9 Bruce BB, Kedar S, Van Stavern GP, Corbett JJ, Newman NJ, Biousse V. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology 2010; 74 (22) 1827-1832
  • 10 Soler D, Cox T, Bullock P, Calver DM, Robinson RO. Diagnosis and management of benign intracranial hypertension. Arch Dis Child 1998; 78 (01) 89-94
  • 11 Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988; 45 (08) 866-872
  • 12 Lee AG, Golnik K, Kardon R, Wall M, Eggenberger E, Yedavally S. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002; 109 (03) 482-485
  • 13 Johnston I, Kollar C, Dunkley S, Assaad N, Parker G. Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci 2002; 9 (03) 273-278
  • 14 Balcer LJ, Liu GT, Forman S. , et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999; 52 (04) 870-872
  • 15 Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999; 127 (02) 178-182
  • 16 Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990; 47 (03) 315-320
  • 17 Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41 (2 Pt 1): 239-244
  • 18 Tugal O, Jacobson R, Berezin S. , et al. Recurrent benign intracranial hypertension due to iron deficiency anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol 1994; 16 (03) 266-270
  • 19 Wall M, Kupersmith MJ, Kieburtz KD. , et al; NORDIC Idiopathic Intracranial Hypertension Study Group. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 2014; 71 (06) 693-701
  • 20 Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980; 55 (09) 541-546
  • 21 Sklar FH, Reisch J, Elashvili I, Smith T, Long DM. Effects of pressure on cerebrospinal fluid formation: nonsteady-state measurements in dogs. Am J Physiol 1980; 239 (03) R277-R284
  • 22 Welch K. The principles of physiology of the cerebrospinal fluid in relation to hydrocephalus including normal pressure hydrocephalus. Adv Neurol 1975; 13: 247-332
  • 23 Sahar A. The effect of pressure on the production of cerebrospinal fluid by the choroid plexus. J Neurol Sci 1972; 16 (01) 49-58
  • 24 Donaldson JO. Cerebrospinal fluid hypersecretion in pseudotumor cerebri. Trans Am Neurol Assoc 1979; 104: 196-198
  • 25 Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974; 97 (02) 301-312
  • 26 Mann JD, Johnson RN, Butler AB, Bass NH. Cerebrospinal fluid circulatory dynamics in pseudotumor cerebri and response to steroid therapy. Neurology 1979; 29: 550
  • 27 Gjerris F, Soelberg Sørensen P, Vorstrup S, Paulson OB. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol 1985; 17 (02) 158-162
  • 28 Janny P, Chazal J, Colnet G, Irthum B, Georget AM. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981; 15 (03) 168-174
  • 29 Alperin N, Ranganathan S, Bagci AM. , et al. MRI evidence of impaired CSF homeostasis in obesity-associated idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2013; 34 (01) 29-34
  • 30 Alperin N, Lam BL, Tain R-W. , et al. Evidence for altered spinal canal compliance and cerebral venous drainage in untreated idiopathic intracranial hypertension. Acta Neurochir Suppl (Wien) 2012; 114: 201-205
  • 31 Farb RI, Vanek I, Scott JN. , et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003; 60 (09) 1418-1424
  • 32 Rohr A, Dörner L, Stingele R, Buhl R, Alfke K, Jansen O. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007; 28 (04) 656-659
  • 33 King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002; 58 (01) 26-30
  • 34 Kanagalingam S, Subramanian PS. Cerebral venous sinus stenting for pseudotumor cerebri: A review. Saudi J Ophthalmol 2015; 29 (01) 3-8
  • 35 Mollan SP, Ball AK, Sinclair AJ. , et al. Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management. Eur Neurol 2009; 62 (02) 105-108
  • 36 Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990; 10 (06) 331-335
  • 37 Corbett JJ, Savino PJ, Thompson HS. , et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39 (08) 461-474
  • 38 Sismanis A, Butts FM, Hughes GB. Objective tinnitus in benign intracranial hypertension: an update. Laryngoscope 1990; 100 (01) 33-36
  • 39 Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 1998; 51 (01) 245-249
  • 40 Rudnick E, Sismanis A. Pulsatile tinnitus and spontaneous cerebrospinal fluid rhinorrhea: indicators of benign intracranial hypertension syndrome. Otol Neurotol 2005; 26 (02) 166-168
  • 41 Chari C, Rao NS. Benign intracranial hypertension--its unusual manifestations. Headache 1991; 31 (09) 599-600
  • 42 Wall M, White II WN. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998; 39 (01) 134-142
  • 43 Greenfield DS, Wanichwecharungruang B, Liebmann JM, Ritch R. Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy. Arch Ophthalmol 1997; 115 (03) 423-426
  • 44 Quattrone A, Bono F, Fera F, Lavano A. Isolated unilateral abducens palsy in idiopathic intracranial hypertension without papilledema. Eur J Neurol 2006; 13 (06) 670-671
  • 45 Biousse V, Rucker JC, Vignal C, Crassard I, Katz BJ, Newman NJ. Anemia and papilledema. Am J Ophthalmol 2003; 135 (04) 437-446
  • 46 Mark S. . Greenberg. Handbook of Neurosurgery. Eighth. Vol. 81, The Yale journal of biology and medicine. New York: Thieme; 2008
  • 47 Galgano MA, Deshaies EM. An update on the management of pseudotumor cerebri. Clin Neurol Neurosurg 2013; 115 (03) 252-259
  • 48 Thurtell MJ, Bruce BB, Newman NJ, Biousse V. An update on idiopathic intracranial hypertension. Rev Neurol Dis 2010; 7 (2-3): e56-e68
  • 49 Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia 2015; 35 (03) 248-261
  • 50 Johnson LN, Krohel GB, Madsen RW, March Jr GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998; 105 (12) 2313-2317
  • 51 Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004; 63 (09) 1737-1739
  • 52 Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994; 118 (01) 88-96